Bioelectrical impedance for detecting upper limb lymphedema in nonlaboratory settings

Lymphatic Research and Biology

Volumn 7, Issue 1, 2009, Pages 11-15

  Ridner, Sheila H ^a   Dietrich, Mary S ^a   Deng, Jie ^a   Bonner, Candace M ^a   Kidd, Nancy ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARM LYMPHEDEMA; ARTICLE; BIOENERGY; BREAST CANCER; CANCER SURVIVOR; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL LABORATORY; CLINICAL PROTOCOL; COMMUNITY CARE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; LYMPHEDEMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STANDING;

ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; FEMALE; HUMANS; LYMPHEDEMA; MIDDLE AGED; QUESTIONNAIRES; SURVIVORS; UPPER EXTREMITY;

EID: 62949135980     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2008.1003     Document Type: Article

References (19)

1. SEER Cancer Statistics Review. National Cancer Institute Web site. Available at: http://seer.cancer.gov/statfacts/ html/breast.html. Accessed on February 4, 2008.
2. Rockson SG. Lymphedema Am J Med 2001;110:288-295.
3. Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol 2005;3:208-217.
4. Petrek JA, Pressman PI, Smith RA. Lymphedema: Current issues in research and management. CA Cancer J Clin 2000;50:292-307.
5. Wilke LG, McCall LM, Poshther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SGA, Lucci A, Cox CE, Hunt KK,Herndon JE, Giuliano AE. Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
6. Armer JM, Fu MR, Wainstock E, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004;37:73-91.
7. Sander AP, Hajer NM, Hemeway K, Miller AC. Upper-extremity volume measurements in women with lymphedema: A comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther 2002;82:1201-1212.
8. Ridner SH, Montgomery LD, Hepworth JT, Stewart BR, Armer JM. Comparison of upper limb volume measurement techniques and arm symptoms between healthy volunteers and individuals with known lymphedema. Lymphology. 2007;40:35-46.
9. Megens AM, Harris SR, Kim-Sing K, Mc Kenzie DC. Measurement of upper extremity volume in women after axillary dissection for breast cancer. Arch Phys Med Rehabil 2001;82:1639-1644.
10. Armer JM. The problem of post-breast cancer lymphedema: Impact and measurement issues. Cancer Invest 2005;23: 76-83.
11. Ward LC. Bioelectric impedance analysis: Proven utility in lymphedema risk assessment and therapeutic monitoring. Lymphat Res Biol 2006;4:51-56.
12. Juzo, Incorporated. Perometer. 2008. Available at: http:// www.Juzousa.com/en/products/Perometer.asp. Accessed on April 21, 2008.
13. Impedimed's Greg Brown: Brisbane to Basle and Back. Biotech Daily. (2008, January) Biotech Daily Web site. Available at: http://www.biotechdaily.net/ impedimed/2/. Accessed on April 11, 2008.
14. Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 2001;34:2-11.
15. Ward LC, Bunce IH, Cornish BH, Mirolo BR, Thomas BJ, Jones LC. Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphedema in post-mastectomy patients. Eur J Clin Invest 1992;22:751-754.
16. Impedimed. Lymphometer: The new tool in monitoring lymphedema. Impedimed, Mansfield, 2002.
17. Cornish B. Bioimpedance analysis: Scientific background. Lymphat Res Biol 2006;4:47-50.
18. Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer 2005;13:904-911.
19. Ridner SH, Dietrich MS. Self-reported co-morbid conditions and medication usage in breast cancer survivors with and without lymphedema. Oncol Nurs Forum 2008;35:57-63.